RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fuso Pharmaceutical Industries Stock

Fuso Pharmaceutical Industries P/E 2024

Fuso Pharmaceutical Industries P/E

14.66

Ticker

4538.T

ISIN

JP3823600006

As of Oct 15, 2024, Fuso Pharmaceutical Industries's P/E ratio was 14.66, a 38.43% change from the 10.59 P/E ratio recorded in the previous year.

The Fuso Pharmaceutical Industries P/E history

Fuso Pharmaceutical Industries Aktienanalyse

What does Fuso Pharmaceutical Industries do?

Fuso Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Fuso Pharmaceutical Industries's P/E Ratio

The Price to Earnings (P/E) Ratio of Fuso Pharmaceutical Industries is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Fuso Pharmaceutical Industries's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Fuso Pharmaceutical Industries is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Fuso Pharmaceutical Industries’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Fuso Pharmaceutical Industries stock

What is the price-to-earnings ratio of Fuso Pharmaceutical Industries?

The price-earnings ratio of Fuso Pharmaceutical Industries is currently 14.66.

How has the price-earnings ratio of Fuso Pharmaceutical Industries changed compared to last year?

The price-to-earnings ratio of Fuso Pharmaceutical Industries has increased by 38.43% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Fuso Pharmaceutical Industries high compared to other companies?

Yes, the price-to-earnings ratio of Fuso Pharmaceutical Industries is high compared to other companies.

How does an increase in the price-earnings ratio of Fuso Pharmaceutical Industries affect the company?

An increase in the price-earnings ratio of Fuso Pharmaceutical Industries would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Fuso Pharmaceutical Industries affect the company?

A decrease in the price-earnings ratio of Fuso Pharmaceutical Industries would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Fuso Pharmaceutical Industries?

Some factors that influence the price-earnings ratio of Fuso Pharmaceutical Industries are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Fuso Pharmaceutical Industries pay?

Over the past 12 months, Fuso Pharmaceutical Industries paid a dividend of 75 JPY . This corresponds to a dividend yield of about 3.21 %. For the coming 12 months, Fuso Pharmaceutical Industries is expected to pay a dividend of 75 JPY.

What is the dividend yield of Fuso Pharmaceutical Industries?

The current dividend yield of Fuso Pharmaceutical Industries is 3.21 %.

When does Fuso Pharmaceutical Industries pay dividends?

Fuso Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Fuso Pharmaceutical Industries?

Fuso Pharmaceutical Industries paid dividends every year for the past 20 years.

What is the dividend of Fuso Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 75 JPY are expected. This corresponds to a dividend yield of 3.21 %.

In which sector is Fuso Pharmaceutical Industries located?

Fuso Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuso Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuso Pharmaceutical Industries from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Fuso Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Fuso Pharmaceutical Industries in the year 2023?

In the year 2023, Fuso Pharmaceutical Industries distributed 75 JPY as dividends.

In which currency does Fuso Pharmaceutical Industries pay out the dividend?

The dividends of Fuso Pharmaceutical Industries are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fuso Pharmaceutical Industries

Our stock analysis for Fuso Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuso Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.